Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 10
Submit an article Journal homepage
93
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor

Vindesine dexamethasone as a therapeutic option in elderly blastic plasmacytoid dendritic cell neoplasms: a monocentric experience

Alyssa Benarfaa Dermatology Department, Bordeaux University Hospital, Bordeaux, France
,
Anne Pham-Ledarda Dermatology Department, Bordeaux University Hospital, Bordeaux, France;b INSERM U1053, Bordeaux research in Translational Oncology, Team 3 oncogenesis of cutaneous lymphomas, Univ. Bordeaux, Bordeaux, FranceORCID Iconhttps://orcid.org/0000-0003-2960-6084
ORCID Icon,
Emilie Gérarda Dermatology Department, Bordeaux University Hospital, Bordeaux, France
,
Laure Dequidta Dermatology Department, Bordeaux University Hospital, Bordeaux, France
,
Océane Ducharmea Dermatology Department, Bordeaux University Hospital, Bordeaux, FranceORCID Iconhttps://orcid.org/0000-0001-8801-2900
ORCID Icon,
Pierre-Yves Dumasc Service d’Hématologie Clinique et de Thérapie Cellulaire, CHU Bordeaux, Bordeaux, France;d INSERM U1035, Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers, Univ Bordeaux, Bordeaux, FranceORCID Iconhttps://orcid.org/0000-0003-0119-3548
ORCID Icon &
Marie Beylot-Barrya Dermatology Department, Bordeaux University Hospital, Bordeaux, France;b INSERM U1053, Bordeaux research in Translational Oncology, Team 3 oncogenesis of cutaneous lymphomas, Univ. Bordeaux, Bordeaux, France;d INSERM U1035, Biotherapy of Genetic Diseases, Inflammatory Disorders and Cancers, Univ Bordeaux, Bordeaux, FranceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-6150-1229
ORCID Icon show all
Pages 2551-2553 | Received 29 Jan 2021, Accepted 14 Apr 2021, Published online: 27 Apr 2021

References

  • Petrella T, Bagot M, Willemze R, et al. Blastic NK-cell lymphomas (agranular CD4 + CD56+ hematodermic neoplasms) – a review. Am J Clin Pathol. 2005;123(5):662–675.
  • Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405.
  • Brüggen MC, Valencak J, Stranzenbach R, et al. Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study. J Eur Acad Dermatol Venereol. 2020;34(7):1489–1495.
  • Laribi K, Baugier de Materre A, Sobh M, et al. Blastic plasmacytoid dendritic cell neoplasms: results of an international survey on 398 adult patients. Blood Adv. 2020;4(19):4838–4848.
  • Pagano L, Valentini CG, Grammatico S, et al. Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches. Br J Haematol. 2016;174(2):188–202.
  • Julia F, Petrella T, Beylot-Barry M, et al. Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. Br J Dermatol. 2013;169(3):579–586.
  • Dalle S, Beylot-Barry M, Bagot M, et al. Blastic plasmacytoid dendritic cell neoplasm: is transplantation the treatment of choice? Br J Dermatol. 2010;162(1):74–79.
  • Garnache-Ottou F, Vidal C, Biichlé S, et al. How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients? Blood Adv. 2019;3(24):4238–4251.
  • Pemmaraju N, Lane AA, Sweet KL, et al. Tagraxofusp in blastic plasmacytoid dendritic-cell neoplasm. N Engl J Med. 2019;380(17):1628–1637.
  • Kerr D, Zhang L, Sokol L. Blastic plasmacytoid dendritic cell neoplasm. Curr Treat Options Oncol. 2019;20(1):9.
  • Beziat G, Ysebaert L, Gaudin C, et al. Venetoclax to treat relapsed blastic plasmacytoid dendritic cell neoplasm: a case-report and review of literature. Leuk Res. 2019;85:106199.
  • Gökbuget N, Hoelzer D. Vindesine in the treatment of leukemia. Leuk Lymphoma. 1997;26:487–506.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.